Copyright for articles published in this journal is retained by the journal.
Author Biographies
A Chaabouni
Department of Urology, Habib Bourguiba University Hospital, Majida Boulila Road, Sfax 3029, Tunisia
K Chabchoub
Department of Urology, Habib Bourguiba University Hospital, Majida Boulila Road, Sfax 3029, Tunisia
N Rebai
Department of Urology, Habib Bourguiba University Hospital, Majida Boulila Road, Sfax 3029, Tunisia
M Bouacida
Department of Urology, Habib Bourguiba University Hospital, Majida Boulila Road, Sfax 3029, Tunisia
MH Slimen
Department of Urology, Habib Bourguiba University Hospital, Majida Boulila Road, Sfax 3029, Tunisia
A Bahloul
Department of Urology, Habib Bourguiba University Hospital, Majida Boulila Road, Sfax 3029, Tunisia
MN Mhiri
Department of Urology, Habib Bourguiba University Hospital, Majida Boulila Road, Sfax 3029, Tunisia
Main Article Content
Testis sparing surgery for Leydig cell tumors: New three cases and review of the current literature
A Chaabouni
K Chabchoub
N Rebai
M Bouacida
MH Slimen
A Bahloul
MN Mhiri
Abstract
Introduction: Leydig cells tumors of the testis are uncommon, representing between 1 and 3% of the testicular tumors and for which the natural history and therapy are debated between radical orchitectomy and organ-sparing surgery. Subjects and methods: We report three new cases of Leydig cells tumors, treated in our department and we discuss the clinical, diagnostic and therapeutic aspects of this uncommon tumor. Results: The mean patient age was 29 years (23–37 years). Medical referral was for a testicular pain in two and gynecomastia in one case. All patients were treated surgically, through an inguinal incision and the procedure included clamping of the spermatic cord. During surgery, frozen section were analyzed in two cases and the tumor enucleation with organ-sparing surgery was performed. The other patient had an unilateral orchidectomy and controlateral tumorectomy. The mean follow-up was 40 months with no local recurrence. Conclusion: Patients diagnosed with Leydig cells tumors have a good prognosis; this study shows the safety of conservative surgery treatment, provided it is subsequently followed by close surveillance, as it preserves maximum fertility, and these tumors usually have a favorable prognosis.
AJOL is a Non Profit Organisation that cannot function without donations.
AJOL and the millions of African and international researchers who rely on our free services are deeply grateful for your contribution.
AJOL is annually audited and was also independently assessed in 2019 by E&Y.
Your donation is guaranteed to directly contribute to Africans sharing their research output with a global readership.
Once off donations here:
For annual AJOL Supporter contributions, please view our Supporters page.
Tell us what you think and showcase the impact of your research!
Please take 5 minutes to contribute to our survey so that we can better understand the contribution that African research makes to global and African development challenges. Share your feedback to help us make sure that AJOL's services support and amplify the voices of researchers like you.